Aveanna Healthcare (AVAH) Financials

$4.54 -0.17 (-3.61%)

Closing price 04/15/2025 04:00 PM Eastern

Extended Trading

$4.82 +0.28 (+6.15%)

As of 04/15/2025 04:58 PM Eastern

Annual Income Statements for Aveanna Healthcare

This table shows Aveanna Healthcare's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	-77	-57	-662	-135	-11
Consolidated Net Income / (Loss)	-77	-57	-662	-135	-11
Net Income / (Loss) Continuing Operations	-77	-57	-662	-135	-11
Total Pre-Tax Income	-75	-52	-664	-139	5.07
Total Operating Income	39	-3.49	-642	8.07	140
Total Gross Profit	419	455	553	595	636
Total Revenue	1,384	1,495	1,788	1,895	2,025
Operating Revenue	1,384	1,495	1,788	1,895	2,025
Total Cost of Revenue	965	1,041	1,234	1,300	1,389
Operating Cost of Revenue	965	1,041	1,234	1,300	1,389
Total Operating Expenses	380	458	1,196	587	496
Selling, General & Admin Expense	228	241	357	361	353
Depreciation Expense	14	17	21	14	11
Other Operating Expenses / (Income)	116	115	142	107	131
Impairment Charge	0.00	76	675	105	0.00
Restructuring Charge	23	9.56	0.10	0.47	1.49
Total Other Income / (Expense), net	-114	-48	-22	-147	-135
Interest Expense	97	83	108	153	157
Interest & Investment Income	0.21	0.35	0.68	0.33	0.50
Other Income / (Expense), net	-17	34	86	5.85	21
Income Tax Expense	1.49	5.32	-1.78	-4.47	16
Basic Earnings per Share	($0.56)	($0.40)	($3.57)	($0.71)	($0.06)
Weighted Average Basic Shares Outstanding	136.91M	140.97M	185.55M	189.96M	192.89M
Diluted Earnings per Share	($0.56)	($0.40)	($3.57)	($0.71)	($0.06)
Weighted Average Diluted Shares Outstanding	136.91M	140.97M	185.55M	189.96M	192.89M
Weighted Average Basic & Diluted Shares Outstanding	136.91M	140.97M	185.86M	192.38M	195.09M

This table shows Aveanna Healthcare's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	24	-238	-32	26	-102	-26	-11	14	-43	29
Consolidated Net Income / (Loss)	24	-238	-32	26	-102	-26	-11	14	-43	29
Net Income / (Loss) Continuing Operations	24	-238	-32	26	-102	-26	-11	14	-43	29
Total Pre-Tax Income	22	-239	-30	25	-102	-32	1.49	3.98	-27	27
Total Operating Income	4.79	-204	18	37	-76	29	23	37	34	46
Total Gross Profit	135	129	144	155	147	148	146	158	160	172
Total Revenue	443	451	466	472	478	479	491	505	509	520
Operating Revenue	443	451	466	472	478	479	491	505	509	520
Total Cost of Revenue	308	322	322	317	331	330	345	347	349	348
Operating Cost of Revenue	308	322	322	317	331	330	345	347	349	348
Total Operating Expenses	130	333	127	118	224	119	123	121	126	126
Selling, General & Admin Expense	90	90	92	91	91	87	88	88	88	89
Depreciation Expense	4.92	4.54	4.04	3.49	2.96	3.28	2.91	2.83	2.59	2.45
Other Operating Expenses / (Income)	35	34	31	23	24	29	32	30	35	33
Restructuring Charge	0.00	0.03	0.07	-0.03	0.43	-	0.00	0.00	0.15	1.34
Total Other Income / (Expense), net	17	-35	-48	-13	-25	-61	-21	-33	-61	-19
Interest Expense	28	34	36	38	40	40	40	40	39	38
Interest & Investment Income	0.16	0.31	0.08	0.11	0.05	0.09	0.10	0.10	0.10	0.20
Other Income / (Expense), net	45	-1.02	-12	25	14	-21	18	6.37	-22	19
Income Tax Expense	-2.67	-1.36	1.57	-0.81	0.63	-5.86	13	-9.93	16	-2.25
Basic Earnings per Share	$0.13	($1.28)	($0.17)	$0.14	($0.54)	($0.14)	($0.06)	$0.07	($0.22)	$0.15
Weighted Average Basic Shares Outstanding	186.11M	185.55M	189.05M	189.07M	189.14M	189.96M	192.24M	192.60M	193.36M	192.89M
Diluted Earnings per Share	$0.13	($1.28)	($0.17)	$0.13	($0.54)	($0.13)	($0.06)	$0.07	($0.22)	$0.15
Weighted Average Diluted Shares Outstanding	186.17M	185.55M	189.05M	189.74M	189.14M	189.96M	192.24M	196.87M	193.36M	192.89M
Weighted Average Basic & Diluted Shares Outstanding	185.92M	185.86M	185.86M	190.43M	190.73M	192.38M	192.38M	193.23M	193.23M	195.09M

This table details how cash moves in and out of Aveanna Healthcare's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	-4.67	134	-8.22	25	40
Net Cash From Operating Activities	-8.71	117	-48	23	33
Net Cash From Continuing Operating Activities	-8.71	117	-48	23	33
Net Income / (Loss) Continuing Operations	-77	-57	-662	-135	-11
Consolidated Net Income / (Loss)	-77	-57	-662	-135	-11
Depreciation Expense	14	17	21	14	11
Amortization Expense	6.72	7.53	25	5.18	5.46
Non-Cash Adjustments To Reconcile Net Income	35	99	609	161	56
Changes in Operating Assets and Liabilities, net	12	50	-42	-22	-29
Net Cash From Investing Activities	-18	-194	-25	-8.79	-6.32
Net Cash From Continuing Investing Activities	-18	-194	-25	-8.79	-6.32
Purchase of Property, Plant & Equipment	-17	-15	-12	-6.12	-6.32
Other Investing Activities, net	-0.23	0.00	0.00	-2.68	0.00
Net Cash From Financing Activities	22	211	62	11	14
Net Cash From Continuing Financing Activities	22	211	65	11	14
Repayment of Debt	17	120	-54	-75	-29
Issuance of Debt	610	14	115	70	25
Issuance of Common Equity	0.00	50	4.02	0.95	3.09
Other Financing Activities, net	-606	29	0.73	15	15
Cash Interest Paid	93	73	103	138	153
Cash Income Taxes Paid	1.55	2.17	1.59	1.14	5.71

This table details how cash moves in and out of Aveanna Healthcare's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	46	-41	15	-6.42	20	-4.35	-1.34	5.05	31	5.83
Net Cash From Operating Activities	21	-40	7.50	-11	29	-3.01	-12	1.81	29	13
Net Cash From Continuing Operating Activities	21	-40	7.50	-11	29	-3.01	-12	1.81	29	13
Net Income / (Loss) Continuing Operations	24	-238	-32	26	-102	-26	-11	14	-43	29
Consolidated Net Income / (Loss)	24	-238	-32	26	-102	-26	-11	14	-43	29
Depreciation Expense	4.92	4.54	4.04	3.49	2.96	3.28	2.91	2.83	2.59	2.45
Amortization Expense	14	7.34	5.66	-2.94	14	-11	7.46	-4.97	1.31	1.66
Non-Cash Adjustments To Reconcile Net Income	-48	213	21	-5.73	94	51	-3.97	18	45	-1.93
Changes in Operating Assets and Liabilities, net	25	-27	8.75	-31	20	-20	-7.20	-28	24	-18
Net Cash From Investing Activities	-3.64	-3.20	-4.80	-1.30	-1.13	-1.57	-1.31	-1.27	-2.21	-1.53
Net Cash From Continuing Investing Activities	-3.64	-3.20	-4.80	-1.30	-1.13	-1.57	-1.31	-1.27	-2.21	-1.53
Purchase of Property, Plant & Equipment	-2.82	-3.21	-2.12	-1.30	-1.13	-1.57	-1.31	-1.27	-2.21	-1.53
Net Cash From Financing Activities	29	-1.03	13	5.40	-7.29	0.22	12	4.51	3.62	-6.05
Net Cash From Continuing Financing Activities	29	2.02	13	5.40	-7.29	0.22	12	4.51	3.62	-6.05
Repayment of Debt	-31	-4.59	-45	-9.23	-11	-9.83	-14	-4.75	-1.06	-9.79
Issuance of Common Equity	-	1.74	0.00	0.95	-	-	1.35	-	1.74	0.00
Other Financing Activities, net	-0.03	4.87	3.01	3.68	3.22	5.05	4.28	4.26	2.95	3.74
Cash Interest Paid	27	33	24	36	39	39	38	39	38	38
Cash Income Taxes Paid	0.41	0.18	-0.39	0.54	0.61	0.37	-0.06	5.00	0.71	0.07

This table presents Aveanna Healthcare's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024
Total Assets	1,844	1,844	1,712	1,613	1,663
Total Current Assets	341	341	270	315	393
Cash & Equivalents	137	137	19	44	84
Accounts Receivable	173	173	221	237	265
Prepaid Expenses	11	11	15	16	17
Other Current Assets	19	19	14	19	26
Plant, Property, & Equipment, net	33	33	23	21	17
Total Noncurrent Assets	1,471	1,471	1,419	1,278	1,253
Noncurrent Note & Lease Receivables	24	24	23	21	22
Goodwill	1,316	1,316	1,160	1,055	1,055
Intangible Assets	74	74	96	94	90
Other Noncurrent Operating Assets	54	54	141	108	87
Total Liabilities & Shareholders' Equity	1,844	1,844	1,712	1,613	1,663
Total Liabilities	1,577	1,577	1,716	1,740	1,785
Total Current Liabilities	260	260	326	355	402
Short-Term Debt	13	9.91	9.20	9.20	9.20
Accounts Payable	57	57	45	30	36
Accrued Expenses	57	57	44	67	88
Other Taxes Payable	25	25	0.00	0.00	0.00
Other Current Liabilities	107	112	229	248	269
Total Noncurrent Liabilities	1,319	1,319	1,392	1,388	1,385
Long-Term Debt	1,163	1,163	1,281	1,276	1,272
Asset Retirement Reserve & Litigation Obligation	54	54	58	62	67
Noncurrent Deferred & Payable Income Tax Liabilities	27	27	3.84	4.86	5.89
Other Noncurrent Operating Liabilities	73	73	48	45	40
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	265	265	-6.31	-130	-124
Total Preferred & Common Equity	265	265	-6.31	-130	-124
Preferred Stock	0.00	0.00	0.00	0.00	0.00
Total Common Equity	265	265	-6.31	-130	-124
Common Stock	723	723	1,230	1,242	1,259
Retained Earnings	-458	-458	-1,237	-1,371	-1,382

This table presents Aveanna Healthcare's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Total Assets	1,973	1,731	1,741	1,655	1,643	1,664	1,644
Total Current Assets	312	308	301	318	336	364	381
Cash & Equivalents	64	34	28	48	43	48	78
Accounts Receivable	219	242	237	236	258	273	265
Prepaid Expenses	13	17	16	12	16	17	12
Other Current Assets	17	16	20	22	20	27	25
Plant, Property, & Equipment, net	25	21	20	22	19	19	18
Total Noncurrent Assets	1,636	1,401	1,420	1,314	1,287	1,281	1,245
Noncurrent Note & Lease Receivables	24	24	27	23	25	24	26
Goodwill	1,368	1,160	1,160	1,055	1,055	1,055	1,055
Intangible Assets	98	98	97	95	93	93	90
Other Noncurrent Operating Assets	146	119	136	142	115	110	75
Total Liabilities & Shareholders' Equity	1,973	1,731	1,741	1,655	1,643	1,664	1,644
Total Liabilities	1,743	1,765	1,746	1,758	1,777	1,782	1,799
Total Current Liabilities	352	376	356	364	382	389	406
Short-Term Debt	9.20	9.20	9.20	9.20	9.20	9.20	9.20
Accounts Payable	49	43	38	37	43	39	42
Current Employee Benefit Liabilities	50	62	-	76	69	73	85
Other Current Liabilities	218	262	248	243	261	268	270
Total Noncurrent Liabilities	1,394	1,391	1,393	1,396	1,397	1,394	1,395
Long-Term Debt	1,283	1,280	1,279	1,278	1,275	1,274	1,275
Capital Lease Obligations	45	43	-	43	39	-	33
Asset Retirement Reserve & Litigation Obligation	61	61	64	67	72	24	73
Noncurrent Deferred & Payable Income Tax Liabilities	2.75	4.44	4.44	4.42	5.47	5.47	5.39
Other Noncurrent Operating Liabilities	2.75	2.45	45	4.04	5.94	91	7.31
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	228	-36	-6.74	-106	-136	-119	-156
Total Preferred & Common Equity	228	-36	-6.74	-106	-136	-119	-156
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	228	-36	-6.74	-106	-136	-119	-156
Common Stock	1,227	1,233	1,236	1,240	1,246	1,250	1,255
Retained Earnings	-999	-1,269	-1,243	-1,345	-1,382	-1,369	-1,411

This table displays calculated financial ratios and metrics derived from Aveanna Healthcare's official financial filings.

Metric	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-
Revenue Growth	0.00%	8.02%	19.57%	6.02%	6.82%
EBITDA Growth	0.00%	29.28%	-1,018.61%	106.44%	439.58%
EBIT Growth	0.00%	41.34%	-1,897.38%	102.50%	1,057.62%
NOPAT Growth	0.00%	-108.95%	-18,319.16%	101.26%	-5,430.76%
Net Income Growth	0.00%	25.44%	-1,060.45%	79.68%	91.88%
EPS Growth	0.00%	28.57%	-792.50%	80.11%	91.55%
Operating Cash Flow Growth	0.00%	1,438.28%	-141.50%	146.84%	43.95%
Free Cash Flow Firm Growth	0.00%	0.00%	-14,707.44%	138.32%	-265.55%
Invested Capital Growth	0.00%	-0.40%	-2.79%	-12.08%	-3.51%
Revenue Q/Q Growth	0.00%	-5.12%	14.08%	1.48%	2.07%
EBITDA Q/Q Growth	0.00%	-43.95%	-42.00%	120.46%	42.15%
EBIT Q/Q Growth	0.00%	-62.84%	-40.54%	106.98%	54.43%
NOPAT Q/Q Growth	0.00%	-102.54%	-23.93%	103.58%	-448.96%
Net Income Q/Q Growth	0.00%	-184.54%	-34.98%	61.18%	83.40%
EPS Q/Q Growth	0.00%	-135.29%	-29.82%	61.83%	82.35%
Operating Cash Flow Q/Q Growth	0.00%	211.44%	-156.11%	255.73%	101.14%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	-6.54%	-5.30%	-246.63%
Invested Capital Q/Q Growth	0.00%	-11.82%	-15.72%	-5.39%	-0.91%
Profitability Metrics	-	-	-	-	-
Gross Margin	30.29%	30.40%	30.95%	31.42%	31.39%
EBITDA Margin	3.10%	3.71%	-28.54%	1.73%	8.76%
Operating Margin	2.81%	-0.23%	-35.93%	0.43%	6.90%
EBIT Margin	1.58%	2.07%	-31.15%	0.73%	7.96%
Profit (Net Income) Margin	-5.53%	-3.82%	-37.03%	-7.10%	-0.54%
Tax Burden Percent	101.98%	110.28%	99.73%	96.78%	-215.48%
Interest Burden Percent	-342.34%	-167.01%	119.23%	-998.32%	3.15%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	315.48%
Return on Invested Capital (ROIC)	2.09%	-0.19%	-35.04%	0.48%	-27.57%
ROIC Less NNEP Spread (ROIC-NNEP)	-7.88%	-5.44%	-53.46%	-10.68%	-3.76%
Return on Net Nonoperating Assets (RNNOA)	-30.96%	-21.34%	-476.72%	197.53%	36.21%
Return on Equity (ROE)	-28.87%	-21.53%	-511.77%	198.00%	8.64%
Cash Return on Invested Capital (CROIC)	0.00%	0.22%	-32.21%	13.33%	-24.00%
Operating Return on Assets (OROA)	1.19%	1.68%	-31.32%	0.84%	9.84%
Return on Assets (ROA)	-4.15%	-3.09%	-37.24%	-8.09%	-0.67%
Return on Common Equity (ROCE)	-28.87%	-21.53%	-511.77%	198.00%	8.64%
Return on Equity Simple (ROE_SIMPLE)	-28.87%	-21.53%	0.00%	103.82%	8.85%
Net Operating Profit after Tax (NOPAT)	27	-2.44	-450	5.65	-301
NOPAT Margin	1.97%	-0.16%	-25.15%	0.30%	-14.88%
Net Nonoperating Expense Percent (NNEP)	9.97%	5.26%	18.42%	11.16%	-23.81%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	0.49%	-26.03%
Cost of Revenue to Revenue	69.71%	69.60%	69.05%	68.58%	68.61%
SG&A Expenses to Revenue	16.46%	16.12%	19.98%	19.05%	17.43%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	27.48%	30.63%	66.88%	30.99%	24.49%
Earnings before Interest and Taxes (EBIT)	22	31	-557	14	161
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	43	56	-510	33	177
Valuation Ratios	-	-	-	-	-
Price to Book Value (P/BV)	1.73	1.73	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.33	0.31	0.08	0.27	0.44
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.15	1.15	1.12	1.58	1.95
Enterprise Value to Revenue (EV/Rev)	1.08	1.00	0.79	0.92	1.04
Enterprise Value to EBITDA (EV/EBITDA)	34.87	26.92	0.00	53.31	11.82
Enterprise Value to EBIT (EV/EBIT)	68.34	48.26	0.00	125.89	13.01
Enterprise Value to NOPAT (EV/NOPAT)	54.93	0.00	0.00	310.20	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	12.82	0.00	77.31	64.25
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	528.40	0.00	11.07	0.00
Leverage & Solvency	-	-	-	-	-
Debt to Equity	4.44	4.43	-204.48	-9.92	-10.37
Long-Term Debt to Equity	4.39	4.39	-203.02	-9.85	-10.29
Financial Leverage	3.93	3.92	8.92	-18.49	-9.63
Leverage Ratio	6.96	6.96	13.74	-24.47	-12.94
Compound Leverage Factor	-23.82	-11.62	16.39	244.27	-0.41
Debt to Total Capital	81.61%	81.57%	100.49%	111.21%	110.68%
Short-Term Debt to Total Capital	0.89%	0.69%	0.72%	0.80%	0.80%
Long-Term Debt to Total Capital	80.72%	80.89%	99.77%	110.41%	109.88%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	18.39%	18.43%	-0.49%	-11.21%	-10.68%
Debt to EBITDA	27.38	21.13	-2.53	39.10	7.22
Net Debt to EBITDA	24.18	18.65	-2.49	37.76	6.74
Long-Term Debt to EBITDA	27.08	20.95	-2.51	38.82	7.17
Debt to NOPAT	43.14	-480.72	-2.87	227.51	-4.25
Net Debt to NOPAT	38.10	-424.46	-2.83	219.74	-3.97
Long-Term Debt to NOPAT	42.67	-476.66	-2.85	225.89	-4.22
Altman Z-Score	0.67	0.75	-1.03	0.16	0.67
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-
Current Ratio	1.31	1.31	0.83	0.89	0.98
Quick Ratio	1.19	1.19	0.74	0.79	0.87
Cash Flow Metrics	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	2.83	-413	158	-262
Operating Cash Flow to CapEx	-52.38%	765.36%	-402.91%	370.70%	516.49%
Free Cash Flow to Firm to Interest Expense	0.00	0.03	-3.84	1.03	-1.67
Operating Cash Flow to Interest Expense	-0.09	1.40	-0.45	0.15	0.21
Operating Cash Flow Less CapEx to Interest Expense	-0.26	1.22	-0.56	0.11	0.17
Efficiency Ratios	-	-	-	-	-
Asset Turnover	0.75	0.81	1.01	1.14	1.24
Accounts Receivable Turnover	8.01	8.65	9.07	8.28	8.07
Inventory Turnover	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	42.39	45.79	64.53	87.54	106.77
Accounts Payable Turnover	17.03	18.36	24.37	34.77	41.73
Days Sales Outstanding (DSO)	45.59	42.21	40.24	44.08	45.23
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	21.44	19.88	14.98	10.50	8.75
Cash Conversion Cycle (CCC)	24.15	22.33	25.26	33.59	36.48
Capital & Investment Metrics	-	-	-	-	-
Invested Capital	1,306	1,301	1,265	1,112	1,073
Invested Capital Turnover	1.06	1.15	1.39	1.59	1.85
Increase / (Decrease) in Invested Capital	0.00	-5.27	-36	-153	-39
Enterprise Value (EV)	1,498	1,495	1,416	1,753	2,097
Market Capitalization	459	459	145	511	900
Book Value per Share	$1.94	$1.88	($0.03)	($0.68)	($0.64)
Tangible Book Value per Share	($8.22)	($7.98)	($6.79)	($6.70)	($6.56)
Total Capital	1,441	1,438	1,284	1,156	1,157
Total Debt	1,176	1,173	1,290	1,286	1,281
Total Long-Term Debt	1,163	1,163	1,281	1,276	1,272
Net Debt	1,039	1,036	1,271	1,242	1,197
Capital Expenditures (CapEx)	17	15	12	6.12	6.32
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-44	-47	-67	-75	-85
Debt-free Net Working Capital (DFNWC)	93	90	-48	-31	-0.30
Net Working Capital (NWC)	80	80	-57	-40	-9.50
Net Nonoperating Expense (NNE)	104	55	212	140	-290
Net Nonoperating Obligations (NNO)	1,041	1,036	1,271	1,242	1,197
Total Depreciation and Amortization (D&A)	21	25	47	19	16
Debt-free, Cash-free Net Working Capital to Revenue	-3.20%	-3.16%	-3.73%	-3.94%	-4.18%
Debt-free Net Working Capital to Revenue	6.72%	6.03%	-2.66%	-1.62%	-0.01%
Net Working Capital to Revenue	5.80%	5.37%	-3.17%	-2.10%	-0.47%
Earnings Adjustments	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$0.00	($0.71)	($0.06)
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	0.00	189.96M	192.89M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$0.00	($0.71)	($0.06)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	0.00	189.96M	192.89M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	0.00	192.38M	195.09M
Normalized Net Operating Profit after Tax (NOPAT)	43	57	23	80	99
Normalized NOPAT Margin	3.12%	3.83%	1.30%	4.20%	4.88%
Pre Tax Income Margin	-5.42%	-3.46%	-37.13%	-7.33%	0.25%
Debt Service Ratios	-	-	-	-	-
EBIT to Interest Expense	0.23	0.37	-5.17	0.09	1.03
NOPAT to Interest Expense	0.28	-0.03	-4.17	0.04	-1.92
EBIT Less CapEx to Interest Expense	0.05	0.19	-5.28	0.05	0.99
NOPAT Less CapEx to Interest Expense	0.11	-0.21	-4.29	0.00	-1.96
Payout Ratios	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	-3.69%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Aveanna Healthcare's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	7.72%	95.68%	3.52%	6.54%	7.90%	6.14%	5.20%	7.00%	6.49%	8.57%
EBITDA Growth	184.12%	-353.31%	-73.79%	114.25%	-165.68%	100.01%	239.32%	-34.57%	134.54%	689,300.00%
EBIT Growth	179.92%	-357.92%	-89.15%	113.88%	-224.60%	103.90%	652.80%	-30.58%	118.99%	708.37%
NOPAT Growth	-86.12%	-154.23%	-1.18%	112.12%	-1,093.85%	114.33%	-1,488.55%	235.12%	144.56%	141.82%
Net Income Growth	1,062.58%	-259.19%	-226.30%	105.40%	-521.39%	89.18%	65.09%	-45.68%	58.16%	213.38%
EPS Growth	1,200.00%	-178.26%	-221.43%	105.08%	-515.38%	89.84%	64.71%	-46.15%	59.26%	215.38%
Operating Cash Flow Growth	-40.82%	-142.61%	179.09%	47.10%	35.43%	92.53%	-259.73%	117.20%	2.42%	546.12%
Free Cash Flow Firm Growth	98.63%	-109.28%	227.20%	182.80%	1,476.76%	262.22%	-108.01%	23.25%	-57.20%	-48.86%
Invested Capital Growth	1.70%	-2.79%	-34.49%	-12.40%	-21.67%	-12.08%	-9.29%	-10.91%	-7.87%	-3.51%
Revenue Q/Q Growth	0.01%	1.84%	3.38%	1.19%	1.29%	0.17%	2.47%	2.92%	0.81%	2.13%
EBITDA Q/Q Growth	115.61%	-379.52%	107.82%	317.28%	-171.97%	100.02%	78.36%	-19.54%	-62.01%	338.75%
EBIT Q/Q Growth	111.06%	-511.56%	102.65%	1,049.53%	-199.28%	112.89%	411.66%	6.00%	-72.84%	448.81%
NOPAT Q/Q Growth	101.68%	-2,761.37%	108.63%	213.57%	-238.04%	138.37%	-936.13%	175.68%	-81.64%	108.20%
Net Income Q/Q Growth	105.13%	-1,078.59%	86.54%	180.00%	-499.97%	74.86%	56.59%	224.47%	-408.09%	168.11%
EPS Q/Q Growth	105.08%	-1,084.62%	86.72%	176.47%	-515.38%	75.93%	53.85%	216.67%	-414.29%	168.18%
Operating Cash Flow Q/Q Growth	206.59%	-289.87%	118.63%	-240.33%	372.87%	-110.47%	-298.40%	115.11%	1,524.88%	-54.39%
Free Cash Flow Firm Q/Q Growth	92.44%	-440.99%	733.69%	-68.05%	25.71%	-36.26%	-131.28%	591.75%	-56.34%	-23.83%
Invested Capital Q/Q Growth	4.89%	-15.72%	-0.23%	-0.69%	-6.21%	-5.39%	2.93%	-2.45%	-3.01%	-0.91%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	30.38%	28.54%	30.97%	32.90%	30.81%	31.00%	29.73%	31.34%	31.37%	33.03%
EBITDA Margin	15.63%	-42.91%	3.25%	13.39%	-9.52%	0.00%	10.48%	8.19%	3.09%	13.26%
Operating Margin	1.08%	-45.32%	3.78%	7.94%	-15.97%	6.12%	4.66%	7.35%	6.68%	8.80%
EBIT Margin	11.27%	-45.55%	1.17%	13.28%	-13.01%	1.67%	8.36%	8.61%	2.32%	12.47%
Profit (Net Income) Margin	5.48%	-52.71%	-6.86%	5.42%	-21.42%	-5.37%	-2.28%	2.75%	-8.42%	5.61%
Tax Burden Percent	112.34%	99.43%	105.15%	103.27%	100.62%	81.46%	-749.80%	349.48%	156.75%	108.33%
Interest Burden Percent	43.32%	116.38%	-558.28%	39.56%	163.57%	-393.95%	3.63%	9.15%	-231.37%	41.55%
Effective Tax Rate	-12.34%	0.00%	0.00%	-3.27%	0.00%	0.00%	849.80%	-249.48%	0.00%	-8.33%
Return on Invested Capital (ROIC)	1.28%	-44.20%	3.00%	11.20%	-15.61%	6.83%	-55.74%	42.34%	8.22%	17.67%
ROIC Less NNEP Spread (ROIC-NNEP)	3.18%	-52.41%	-0.47%	10.15%	-19.44%	3.15%	-43.31%	33.06%	2.93%	16.00%
Return on Net Nonoperating Assets (RNNOA)	6.45%	-467.36%	-1.92%	130.70%	-406.13%	-58.22%	648.79%	-656.23%	-28.17%	-154.13%
Return on Equity (ROE)	7.72%	-511.56%	1.08%	141.90%	-421.73%	-51.39%	593.05%	-613.89%	-19.95%	-136.45%
Cash Return on Invested Capital (CROIC)	-26.07%	-32.21%	13.64%	5.68%	12.50%	13.33%	10.52%	12.30%	15.84%	-24.00%
Operating Return on Assets (OROA)	8.99%	-45.80%	1.03%	13.33%	-13.40%	1.91%	9.52%	9.88%	2.79%	15.41%
Return on Assets (ROA)	4.38%	-52.99%	-6.03%	5.45%	-22.05%	-6.13%	-2.59%	3.16%	-10.12%	6.94%
Return on Common Equity (ROCE)	7.72%	-511.56%	1.08%	141.90%	-421.73%	-51.39%	593.05%	-613.89%	-19.95%	-136.45%
Return on Equity Simple (ROE_SIMPLE)	-215.16%	0.00%	2,005.70%	3,263.77%	327.84%	0.00%	83.43%	105.40%	42.09%	0.00%
Net Operating Profit after Tax (NOPAT)	5.38	-143	12	39	-53	21	-171	130	24	50
NOPAT Margin	1.21%	-31.72%	2.65%	8.20%	-11.18%	4.28%	-34.94%	25.70%	4.68%	9.54%
Net Nonoperating Expense Percent (NNEP)	-1.90%	8.21%	3.47%	1.05%	3.83%	3.68%	-12.43%	9.28%	5.29%	1.67%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	1.77%	-	-	-	4.28%
Cost of Revenue to Revenue	69.62%	71.46%	69.03%	67.10%	69.19%	69.00%	70.27%	68.66%	68.63%	66.97%
SG&A Expenses to Revenue	20.21%	19.94%	19.66%	19.34%	19.04%	18.17%	17.92%	17.42%	17.32%	17.07%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	29.30%	73.86%	27.19%	24.95%	46.78%	24.88%	25.07%	23.99%	24.69%	24.23%
Earnings before Interest and Taxes (EBIT)	50	-205	5.45	63	-62	8.02	41	43	12	65
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	69	-194	15	63	-45	0.01	51	41	16	69
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.18	0.08	0.11	0.17	0.12	0.27	0.25	0.27	0.50	0.44
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.03	1.12	1.18	1.26	1.28	1.58	1.54	1.58	2.07	1.95
Enterprise Value to Revenue (EV/Rev)	0.99	0.79	0.83	0.86	0.81	0.92	0.92	0.90	1.13	1.04
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	53.31	20.59	27.78	17.93	11.82
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	125.89	35.55	58.22	21.45	13.01
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	310.20	189.05	195.12	25.93	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	17.99	0.00	0.00	0.00	0.00	77.31	549.10	113.73	137.94	64.25
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	6.86	20.63	9.02	11.07	13.90	12.12	12.52	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	5.86	-204.48	-37.14	-191.18	-12.58	-9.92	-9.71	-10.79	-8.42	-10.37
Long-Term Debt to Equity	5.82	-203.02	-36.89	-189.81	-12.49	-9.85	-9.64	-10.71	-8.36	-10.29
Financial Leverage	2.03	8.92	4.06	12.88	20.89	-18.49	-14.98	-19.85	-9.61	-9.63
Leverage Ratio	4.00	13.74	6.52	18.87	29.68	-24.47	-19.60	-27.09	-12.58	-12.94
Compound Leverage Factor	1.73	16.00	-36.39	7.47	48.55	96.39	-0.71	-2.48	29.12	-5.38
Debt to Total Capital	85.43%	100.49%	102.77%	100.53%	108.64%	111.21%	111.48%	110.22%	113.47%	110.68%
Short-Term Debt to Total Capital	0.59%	0.72%	0.71%	0.72%	0.75%	0.80%	0.77%	0.79%	0.79%	0.80%
Long-Term Debt to Total Capital	84.84%	99.77%	102.06%	99.81%	107.89%	110.41%	110.70%	109.43%	112.68%	109.88%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	14.57%	-0.49%	-2.77%	-0.53%	-8.64%	-11.21%	-11.48%	-10.22%	-13.47%	-10.68%
Debt to EBITDA	-3.72	-2.53	-2.41	-28.01	-8.27	39.10	15.49	20.18	10.56	7.22
Net Debt to EBITDA	-3.54	-2.49	-2.35	-27.40	-7.97	37.76	14.99	19.43	9.93	6.74
Long-Term Debt to EBITDA	-3.69	-2.51	-2.39	-27.81	-8.21	38.82	15.38	20.03	10.49	7.17
Debt to NOPAT	-3.68	-2.87	-2.98	-12.73	-8.42	227.51	142.17	141.74	15.27	-4.25
Net Debt to NOPAT	-3.51	-2.83	-2.90	-12.45	-8.11	219.74	137.59	136.47	14.36	-3.97
Long-Term Debt to NOPAT	-3.66	-2.85	-2.96	-12.64	-8.36	225.89	141.18	140.72	15.16	-4.22
Altman Z-Score	0.24	-0.35	0.05	0.24	-0.09	0.15	0.20	0.27	0.34	0.48
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.89	0.83	0.82	0.85	0.87	0.89	0.88	0.94	0.94	0.98
Quick Ratio	0.80	0.74	0.74	0.75	0.78	0.79	0.79	0.82	0.85	0.87
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-20	-107	677	216	272	173	-54	266	116	89
Operating Cash Flow to CapEx	752.79%	-1,252.29%	353.20%	-809.70%	2,546.58%	-191.65%	-915.29%	142.55%	1,328.24%	876.78%
Free Cash Flow to Firm to Interest Expense	-0.69	-3.14	18.82	5.69	6.86	4.36	-1.37	6.73	2.96	2.33
Operating Cash Flow to Interest Expense	0.74	-1.18	0.21	-0.28	0.72	-0.08	-0.30	0.05	0.75	0.35
Operating Cash Flow Less CapEx to Interest Expense	0.65	-1.28	0.15	-0.31	0.70	-0.12	-0.34	0.01	0.69	0.31
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.80	1.01	0.88	1.00	1.03	1.14	1.14	1.15	1.20	1.24
Accounts Receivable Turnover	7.68	9.07	7.47	7.58	8.21	8.28	7.69	7.65	7.92	8.07
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	55.45	64.53	70.81	77.44	79.61	87.54	93.92	99.94	99.08	106.77
Accounts Payable Turnover	23.08	24.37	25.04	27.66	30.22	34.77	30.85	34.88	34.96	41.73
Days Sales Outstanding (DSO)	47.55	40.24	48.85	48.15	44.46	44.08	47.48	47.71	46.11	45.23
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	15.81	14.98	14.58	13.20	12.08	10.50	11.83	10.46	10.44	8.75
Cash Conversion Cycle (CCC)	31.73	25.26	34.27	34.95	32.38	33.59	35.65	37.24	35.67	36.48
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,501	1,265	1,262	1,253	1,175	1,112	1,145	1,117	1,083	1,073
Invested Capital Turnover	1.05	1.39	1.13	1.37	1.40	1.59	1.60	1.65	1.76	1.85
Increase / (Decrease) in Invested Capital	25	-36	-664	-177	-325	-153	-117	-137	-93	-39
Enterprise Value (EV)	1,552	1,416	1,491	1,574	1,508	1,753	1,760	1,766	2,238	2,097
Market Capitalization	279	145	193	314	227	511	479	531	999	900
Book Value per Share	$1.23	($0.03)	($0.19)	($0.04)	($0.56)	($0.68)	($0.71)	($0.62)	($0.81)	($0.64)
Tangible Book Value per Share	($6.66)	($6.79)	($6.96)	($6.80)	($6.59)	($6.70)	($6.68)	($6.58)	($6.73)	($6.56)
Total Capital	1,564	1,284	1,296	1,281	1,224	1,156	1,187	1,164	1,161	1,157
Total Debt	1,336	1,290	1,332	1,288	1,329	1,286	1,323	1,283	1,318	1,281
Total Long-Term Debt	1,327	1,281	1,323	1,279	1,320	1,276	1,314	1,274	1,309	1,272
Net Debt	1,273	1,271	1,298	1,260	1,281	1,242	1,281	1,235	1,239	1,197
Capital Expenditures (CapEx)	2.82	3.21	2.12	1.30	1.13	1.57	1.31	1.27	2.21	1.53
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-94	-67	-92	-73	-85	-75	-79	-64	-94	-85
Debt-free Net Working Capital (DFNWC)	-30	-48	-58	-45	-37	-31	-37	-16	-15	-0.30
Net Working Capital (NWC)	-40	-57	-67	-54	-46	-40	-46	-25	-25	-9.50
Net Nonoperating Expense (NNE)	-19	95	44	13	49	46	-160	116	67	20
Net Nonoperating Obligations (NNO)	1,273	1,271	1,298	1,260	1,281	1,242	1,281	1,235	1,239	1,197
Total Depreciation and Amortization (D&A)	19	12	9.70	0.55	17	-8.01	10	-2.14	3.90	4.11
Debt-free, Cash-free Net Working Capital to Revenue	-6.00%	-3.73%	-5.13%	-3.99%	-4.56%	-3.94%	-4.13%	-3.26%	-4.74%	-4.18%
Debt-free Net Working Capital to Revenue	-1.94%	-2.66%	-3.22%	-2.46%	-1.97%	-1.62%	-1.91%	-0.82%	-0.78%	-0.01%
Net Working Capital to Revenue	-2.53%	-3.17%	-3.73%	-2.96%	-2.47%	-2.10%	-2.39%	-1.29%	-1.24%	-0.47%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.13	($1.28)	($0.17)	$0.14	($0.54)	($0.14)	($0.06)	$0.07	($0.22)	$0.15
Adjusted Weighted Average Basic Shares Outstanding	186.11M	185.55M	189.05M	189.07M	189.14M	189.96M	192.24M	192.60M	193.36M	192.89M
Adjusted Diluted Earnings per Share	$0.13	($1.28)	($0.17)	$0.13	($0.54)	($0.13)	($0.06)	$0.07	($0.22)	$0.15
Adjusted Weighted Average Diluted Shares Outstanding	186.17M	185.55M	189.05M	189.74M	189.14M	189.96M	192.24M	196.87M	193.36M	192.89M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	185.92M	185.86M	185.86M	190.43M	190.73M	192.38M	192.38M	193.23M	193.23M	195.09M
Normalized Net Operating Profit after Tax (NOPAT)	3.35	-143	12	26	20	21	16	26	24	33
Normalized NOPAT Margin	0.76%	-31.72%	2.66%	5.56%	4.28%	4.28%	3.26%	5.15%	4.70%	6.34%
Pre Tax Income Margin	4.88%	-53.01%	-6.52%	5.25%	-21.29%	-6.60%	0.30%	0.79%	-5.37%	5.18%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	1.75	-6.05	0.15	1.65	-1.57	0.20	1.04	1.10	0.30	1.70
NOPAT to Interest Expense	0.19	-4.21	0.34	1.02	-1.35	0.52	-4.32	3.28	0.61	1.30
EBIT Less CapEx to Interest Expense	1.66	-6.14	0.09	1.62	-1.60	0.16	1.00	1.07	0.24	1.66
NOPAT Less CapEx to Interest Expense	0.09	-4.31	0.28	0.99	-1.38	0.48	-4.36	3.24	0.55	1.26
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Aveanna Healthcare's Financials

When does Aveanna Healthcare's fiscal year end?

According to the most recent income statement we have on file, Aveanna Healthcare's financial year ends in December. Their financial year 2024 ended on December 28, 2024.

How has Aveanna Healthcare's net income changed over the last 4 years?

Aveanna Healthcare's net income appears to be on a downward trend, with a most recent value of -$10.93 million in 2024, falling from -$76.52 million in 2020. The previous period was -$134.52 million in 2023.

What is Aveanna Healthcare's operating income?

Aveanna Healthcare's total operating income in 2024 was $139.79 million, based on the following breakdown:

Total Gross Profit: $635.54 million
Total Operating Expenses: $495.76 million

How has Aveanna Healthcare revenue changed over the last 4 years?

Over the last 4 years, Aveanna Healthcare's total revenue changed from $1.38 billion in 2020 to $2.02 billion in 2024, a change of 46.3%.

How much debt does Aveanna Healthcare have?

Aveanna Healthcare's total liabilities were at $1.79 billion at the end of 2024, a 2.6% increase from 2023, and a 13.2% increase since 2020.

How much cash does Aveanna Healthcare have?

In the past 4 years, Aveanna Healthcare's cash and equivalents has ranged from $19.22 million in 2022 to $137.35 million in 2020, and is currently $84.29 million as of their latest financial filing in 2024.

How has Aveanna Healthcare's book value per share changed over the last 4 years?

Over the last 4 years, Aveanna Healthcare's book value per share changed from 1.94 in 2020 to -0.64 in 2024, a change of -133.0%.

Remove Ads

Related Companies

This page (NASDAQ:AVAH) was last updated on 4/16/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Aveanna Healthcare (AVAH) Financials

Frequently Asked Questions About Aveanna Healthcare's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Aveanna Healthcare (AVAH) Financials

Annual Income Statements for Aveanna Healthcare

Quarterly Income Statements for Aveanna Healthcare

Annual Cash Flow Statements for Aveanna Healthcare

Quarterly Cash Flow Statements for Aveanna Healthcare

Annual Balance Sheets for Aveanna Healthcare

Quarterly Balance Sheets for Aveanna Healthcare

Annual Metrics and Ratios for Aveanna Healthcare

Quarterly Metrics and Ratios for Aveanna Healthcare

Frequently Asked Questions About Aveanna Healthcare's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools